Localized lipoatrophy and inadvertent subcutaneous administration of a COVID-19 vaccine.
Hum Vaccin Immunother
; 18(5): 2042136, 2022 11 30.
Article
in English
| MEDLINE | ID: covidwho-1730550
ABSTRACT
A 60-year-old woman presented with a depressed lesion at the site of her first COVID-19 (Astra Zeneca) vaccine injection. The lesion was diagnosed as a case of injection related localized lipoatrophy as markers of autoimmune disease were negative and biopsy differentiated it from localized involutional lipoatrophy. This case of localized lipoatrophy was likely due to inadvertent subcutaneous injection of the COVID-19 vaccine with a 16 mm long needle.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Lipodystrophy
Type of study:
Case report
/
Observational study
Topics:
Vaccines
Limits:
Female
/
Humans
/
Middle aged
Language:
English
Journal:
Hum Vaccin Immunother
Year:
2022
Document Type:
Article
Affiliation country:
21645515.2022.2042136
Similar
MEDLINE
...
LILACS
LIS